Physiomics (LON:PYC) Shares Up 8.6% – Should You Buy?

Physiomics Plc (LON:PYCGet Free Report)’s share price rose 8.6% during mid-day trading on Wednesday . The stock traded as high as GBX 0.55 and last traded at GBX 0.52. Approximately 20,602,037 shares changed hands during mid-day trading, an increase of 241% from the average daily volume of 6,044,670 shares. The stock had previously closed at GBX 0.47.

Physiomics Stock Performance

The company has a market cap of £2.34 million, a PE ratio of -3.44 and a beta of 1.05. The company has a 50 day simple moving average of GBX 0.49 and a two-hundred day simple moving average of GBX 0.50.

About Physiomics

(Get Free Report)

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

See Also

Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.